AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies

Thangaratinam, Shakila; Marlin, Nadine; Newton, Sian; Weckesser, Annalise; Bagary, Manny; Greenhill, Lynette; Rikunenko, Rachel; D’Amico, Maria; Rogozińska, Ewelina; Kelso, Andrew; Hard, Kelly; Coleman, Jamie; Moss, Ngawai; Roberts, Tracy; Middleton, Lee; Dodds, Julie; Pullen, Angela; Eldridge, Sandra; Pirie, Alexander; Denny, Elaine; McCorry, Doug; Khan, Khalid S

doi:10.3310/hta22230

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

Extended Research Article

Toolkit

View Award

There is no evidence that regular monitoring of anti-epileptic drug levels in pregnancy improves seizure control compared with clinical features-based monitoring.

Shakila Thangaratinam, Nadine Marlin, Sian Newton, Annalise Weckesser, Manny Bagary, Lynette Greenhill, Rachel Rikunenko, Maria D’Amico, Ewelina Rogozińska, Andrew Kelso, Kelly Hard, Jamie Coleman, Ngawai Moss, Tracy Roberts, Lee Middleton, Julie Dodds, Angela Pullen, Sandra Eldridge, Alexander Pirie, Elaine Denny, Doug McCorry & Khalid S Khan.

Detailed Author information
Detailed Author information

Shakila Thangaratinam ^1,^2,^3,^*, Nadine Marlin ³, Sian Newton ^1,³, Annalise Weckesser ⁴, Manny Bagary ⁵, Lynette Greenhill ⁵, Rachel Rikunenko ⁶, Maria D’Amico ^1,³, Ewelina Rogozińska ^1,², Andrew Kelso ⁷, Kelly Hard ⁸, Jamie Coleman ⁹, Ngawai Moss ¹⁰, Tracy Roberts ¹¹, Lee Middleton ¹², Julie Dodds ^1,^2,³, Angela Pullen ¹³, Sandra Eldridge ³, Alexander Pirie ⁸, Elaine Denny ⁴, Doug McCorry ⁵, Khalid S Khan ^1,^2,³

¹ Women’s Health Research Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
² Multidisciplinary Evidence Synthesis Hub (mEsh), Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
³ Pragmatic Clinical Trials Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
⁴ Centre for Health and Social Care Research, Birmingham City University, Birmingham, UK
⁵ Neuropsychiatry Department, The Barberry, Birmingham, UK
⁶ Research and Development, Birmingham Children’s Hospital, Birmingham, UK
⁷ Department of Neurology, Royal London Hospital, London, UK
⁸ Research and Development, Birmingham Women’s Hospital, Birmingham, UK
⁹ School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
¹⁰ Patient and Public Involvement group member, Katie’s Team, Katherine Twining Network, Queen Mary University of London, London, UK
¹¹ Health Economics Unit, University of Birmingham, Birmingham, UK
¹² Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
¹³ Epilepsy Action, Leeds, UK
^* Corresponding author Email: s.thangaratinam@qmul.ac.uk

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Report Content

Full Report
Abstract
Plain English Summary
Plain Language Summary
Scientific Summary

The full text of this issue is available as a PDF document from the Toolkit section on this page.

Responses to this report

No responses have been published.

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors. Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

Enter response message*

Name (title, first name, last name)*

Occupation / Job title*

Affiliation / Employer*

Email*

Other authors
For example, if you are responding as a team or group. Please ensure you include full names and separate these using commas

Statement of competing interests
We believe that readers should be aware of any competing interests (conflicts of interest).
The International Committee of Medical Journal Editors (ICMJE) define competing interests as including: financial relationships with industry (for example through employment, consultancies, stock, ownership, honoraria, and expert testimony), either directly or through immediate family; personal relationships; academic competition; and intellectual passion.

If yes, please provide details below

Enter response title*

Enter CAPTCHA What is nine minus one?*

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document